Sarah Cannon | Strategic Alliance Partners

Latest from Sarah Cannon


Johnson Assumes Director Post of Lung Cancer Research at Sarah Cannon Research Institute

January 12, 2021

Melissa Johnson, MD, shares her goals for the first 100 days as program director of the Lung Cancer Research at Sarah Cannon Research Institute, the current state of the anti-TIGIT antibody tiragolumab, and the future of lung cancer treatment.

Lung Cancer: Co-Chaired by David Spigel, MD and Melissa L. Johnson, MD

December 03, 2020

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.

Gastrointestinal Malignancies: Chaired by Johanna Bendell, MD

November 17, 2020

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of gastrointestinal cancers.

x